Showing results (1311-1320 of 1,342) with videos related to
Sort By:
Pageof 135
Annals of the New York Academy of Sciences|July 23, 1999
Androgens and dry eye in Sjögren's syndromeD A Sullivan, L A Wickham, E M Rocha, et al.Nature Communications|May 12, 2021
Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeuticXuqing Zhang, Mengyao Luo, Shamael R Dastagir, et al.Journal of Medicinal Chemistry|September 30, 2005
Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3Zhen Li, Weirong Chen, Jeffrey J Hale, et al.BJU International|March 31, 2022
High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centresElizabeth A Connolly, Andrew Weickhardt, Peter Grimison, et al.British Journal of Haematology|March 9, 2011
Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemiaLetizia Foroni, Gill Wilson, Gareth Gerrard, et al.Nature Genetics|May 6, 2003
Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaMarianne Abifadel, Mathilde Varret, Jean-Pierre Rabès, et al.The Journal of Pharmacology and Experimental Therapeutics|December 15, 2016
Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ Di Salvo, H Nagabukuro, L A Wickham, et al.Nature Nanotechnology|September 1, 2015
Routing of individual polymers in designed patternsJakob Bach Knudsen, Lei Liu, Anne Louise Bank Kodal, et al.Cancer Discovery|March 20, 2021
<i>ZFTA</i> Translocations Constitute Ependymoma Chromatin Remodeling and Transcription FactorsRobert Kupp, Lisa Ruff, Sabrina Terranova, et al.JCI Insight|March 22, 2024
GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetesGene I Uenishi, Marko Repic, Jennifer Y Yam, et al.Pageof 135